METFORMIN HYDROCHLORIDE
| Brand name | RIOMET ER |
|---|---|
| Active ingredient | METFORMIN HYDROCHLORIDE |
| Strength | 500MG/5ML |
| Dosage form | FOR SUSPENSION, EXTENDED RELEASE |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | August 2019 |
| Marketing status | DISCN |
| Patent | Expires | Type |
|---|---|---|
| 9962336 | May 2035 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.